International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease

Purpose Positron emission tomography (PET) with the first and only tau targeting radiotracer of 18 F-flortaucipir approved by FDA has been increasingly used in depicting tau pathology deposition and distribution in patients with cognitive impairment. The goal of this international consensus is to he...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of nuclear medicine and molecular imaging 2022-02, Vol.49 (3), p.895-904
Hauptverfasser:	Tian, Mei, Civelek, A. Cahid, Carrio, Ignasi, Watanabe, Yasuyoshi, Kang, Keon Wook, Murakami, Koji, Garibotto, Valentina, Prior, John O., Barthel, Henryk, Zhou, Rui, Hou, Haifeng, Dou, Xiaofeng, Jin, Chentao, Zuo, Chuantao, Zhang, Hong
Format:	Artikel
Sprache:	eng
Schlagworte:	Alzheimer's disease Cardiology Cognitive ability Fluorine isotopes Guidelines Image acquisition Imaging Medical imaging Medicine Medicine & Public Health Neurodegenerative diseases Neurology Nuclear Medicine Oncology Orthopedics Patients Positron emission Positron emission tomography Radioactive tracers Radiology Tau protein Tomography
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!